Showing results (831-840 of 1,609) with videos related to
Sort By:
Pageof 161
JAMA Oncology|August 18, 2022
Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System: The TOPIC-NEC Phase 3 Randomized Clinical TrialChigusa Morizane, Nozomu Machida, Yoshitaka Honma, et al.JAMA Oncology|December 23, 2021
Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell CarcinomaRobert J Motzer, Thomas Powles, Michael B Atkins, et al.JAMA Oncology|December 23, 2021
Human Leukocyte Antigen Class I Antigen-Processing Machinery Upregulation by Anticancer Therapies in the Era of Checkpoint Inhibitors: A ReviewAnanthan Sadagopan, Theodoros Michelakos, Gabriella Boyiadzis, et al.JAMA Oncology|September 22, 2022
Adoption of Extended-Interval Dosing of Single-Agent Pembrolizumab and Comparative Effectiveness vs Standard Dosing in Time-to-Treatment DiscontinuationGarth W Strohbehn, Robert Holleman, Jennifer Burns, et al.JAMA Oncology|September 22, 2022
Association of QTc Formula With the Clinical Management of Patients With CancerDaniel R Richardson, P Christopher Parish, Xianming Tan, et al.JAMA Oncology|January 20, 2022
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 CohortsAmar U Kishan, Alison Steigler, James W Denham, et al.JAMA Oncology|November 18, 2021
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical TrialEmmanouil Fokas, Anke Schlenska-Lange, Bülent Polat, et al.JAMA Oncology|December 9, 2021
Efficacy of Treatment With Armodafinil for Cancer-Related Fatigue in Patients With High-grade Glioma: A Phase 3 Randomized Clinical TrialAlyx B Porter, Heshan Liu, Sadhna Kohli, et al.JAMA Oncology|November 24, 2021
Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry, David J Pinato, Meera Patel, et al.JAMA Oncology|November 4, 2021
Uptake and Survival Outcomes Following Immune Checkpoint Inhibitor Therapy Among Trial-Ineligible Patients With Advanced Solid CancersRavi B Parikh, Eun Jeong Min, E Paul Wileyto, et al.Pageof 161